New approaches to testing cancer drugs needed - ESMO commentary

Research institutes, regulators and the pharmaceutical industry are urged to cooperate to develop new approaches to testing cancer drugs, in order to bring the revolution in personalised medicine to patients across Europe, says the European Society for Medical Oncology. It has become clear in recent years that each patient’s cancer has individual characteristics that are potentially amenable to “personalised” treatments that target those characteristics. But there is still a great deal of work to be done to ensure patients benefit from these developments as quickly as possible. Read more here.